Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
14)/t4-/m0/s1
MDA-MB-231 breast
VPC-14337 (0-500 nM) inhibits proliferation of MCF-7 (luminal)
4]diazepin-6-yl)acetamido)hexyl)thio)-3-methylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
as well as PARP cleavage
Saxagliptin hydrate esceinamine Isomer II 14)/t4-/m0/s1Saxagliptin, also known as BMS 477118, is a new oral hypoglycemic (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose
US$ 14.90
US$ 45.00
US$ 30.00